UnitedHealth Group reported second-quarter earnings that significantly exceeded Wall Street expectations, prompting the company to raise its full-year adjusted earnings forecast from over $18.25 to a range of $19.50 to $20 per share. The insurer posted adjusted earnings per share of $6.38, compared to the $4.90 analysts had anticipated, and generated $112.03 billion in revenue, outperforming the forecasted $110.85 billion. Despite persistent high medical costs, UnitedHealth’s efforts to control expenses and enhance operational efficiency, partly through a $1.5 billion investment in artificial intelligence (AI), contributed to the positive results.

The company is actively pursuing a turnaround by streamlining operations, shrinking membership, and terminating unprofitable contracts in order to stabilize margins. CFO Wayne DeVeydt emphasized that the company is using AI to improve processes such as prior authorizations, fraud detection, payment accuracy, and overall efficiency without compromising patient care decisions. These initiatives have led to improvements in the medical benefit ratio, which dropped to 86.7% from 89.4% a year earlier, indicating better profitability by paying out less in benefits relative to premiums collected.

Membership declined by 525,000 to 48.5 million during the second quarter, attributed largely to affordability pressures as healthcare costs continue to rise. UnitedHealth expects further losses in both Affordable Care Act exchange and Medicare Advantage plan enrollments in 2026, projecting a decline of about 500,000 and 1.1 million members, respectively. Despite the enrollment drop, the company’s revenue remained stable due to higher premium pricing offsetting the membership losses. DeVeydt acknowledged that while the pricing dynamic maintains revenue, it poses long-term challenges for the healthcare system.

UnitedHealth continues to deal with external challenges, including a Department of Justice investigation into its Medicare billing practices, with no new updates provided. The company’s strong earnings beat, combined with its cost-controlling measures and AI-driven operational improvements, led to a stock rise of more than 7% in morning trading following the earnings release. DeVeydt stressed that the current financial turnaround represents the early stages of a multiyear process aimed at restoring profitability and positioning UnitedHealth as both a solution provider and a profitable healthcare leader.